POSTOPERATIVE PAIN MANAGEMENT MARKET ANALYSIS

Market News

Key Developments

1. Major market players are involved in various business strategies such as gaining product approval from regulatory authorities, in order to cater the global market. For instance, in July 2019, Alembic Pharmaceuticals, an India-based pharmaceutical company, received the U.S. Food and Drug Administration (FDA) approval for pregabalin capsules, which are indicated for neuropathic pain.
2. Key players in the market are focused on different business strategies such as gaining product approval from regulatory authorities, in order to enhance the global market presence. For instance, in July 2019, InvaGen Pharmaceuticals, a subsidiary company of Cipla Limited, received the FDA approval for its generic version of pregabalin capsules. These capsules are indicated for management of neuropathic pain associated with certain diseases.
3. Key players in the market are focused on different business strategies such as gaining product approval from regulatory authorities, in order to gain competitive edge in the global market. For instance, in August 2019, BioElectronics Corporation received the U.S. FDA approval for its RecoveryRX device, which is indicated for treatment of postoperative pain.